Assessing technological impact on vaccine supply chain performance

Abstract

PurposeThe study aims to develop an integrated quantitative approach and suggest a framework to assess the impact of a technological intervention on the internal process dimension of the vaccine supply chain (VSC) system for multiple administered regions.Design/methodology/approachAn evaluation index system is developed by selecting suitable performance indicators (PIs) that define the objectives of a VSC. Then multicriteria decision-making (MCDM) methods are applied to obtain pre and post-intervention relative ranks for the regions and performance scores of the objectives. A bilateral data envelopment analysis (DEA) compares significant efficiency differences between improvement and deterioration groups.FindingsThis study demonstrates that technological intervention improves the internal process dimension of a VSC for the regions under consideration. The empirical study delivers two groups of regions showing improvement or deterioration in relative performance ranking due to the technological intervention. However, the efficiency-based bilateral comparison may reveal an insignificant difference between the two groups.Practical implicationsDecision-makers associated with VSC will find the suggested model helpful in assessing the impact of technological intervention. They can easily identify specific objectives of VSC's internal process dimension, whether a particular region has observed an improvement or deterioration in its relative performance and maximize the outcome by focusing on the areas of concern for a specific region.Originality/valueThis study is the first to provide a quantitative approach that empirically determines relative performance improvement or deterioration of different regions for a set of identified VSC objectives in the context of the Indian states.

A decision support method for credit risk based on the dynamic Bayesian network

“…MCDM provides a solid methodological basis to resolve the inherent multi-criteria nature of the problem (Cui et al ., 2022). The strength of MCDM lies in its ability to rank decisions (Rai et al ., 2022). The representative MCDM are analytic hierarchy process (AHP) (Duong et al ., 2020), analytic network process (ANP) (Fosso Wamba et al ., 2023), Vise Kriterijumska Optimizacija I Kompromisno Resenje (VIKOR) (Ghadge et al ., 2021), technique for order preference by similarity to an ideal solution (TOPSIS) (Kumar Roy et al ., 2022), elimination and choice translating reality (ELECTRE) (Doumpos and Figueira, 2019), decision making trial and evaluation laboratory (DEMATEL) (He et al ., 2021), best worst method (BWM) (Kumar Roy et al ., 2022), fuzzy set theory (FS) (Guo et al ., 2020) and grey theory (Mao et al ., 2020), etc.…”

An incentive mechanism contract model to coordinate a vaccine supply chain under demand uncertainty

“…Salarpour and Nagurney (2021) model the international rivalry for scarce medical supplies during the COVID-19 disaster planning and response stages by building the Vaccine supply chain under demand uncertainty first stochastic Generalized Nash Equilibrium model. Rai et al (2022) evaluate the effect of technology on VSC performance using multi-criteria decision-making (MCDM) and bilateral data envelopment analysis (DEA). They show that the internal process dimension of a VSC is enhanced by technological intervention in the regions under consideration.…”

“…Today's VSCs face huge demands involving fewer vaccine suppliers, complex vaccination schedules, multiple stakeholders, inefficient logistics and supply chains and regulatory issues (Rai et al ., 2022; Hu et al ., 2023; Linnander et al ., 2022; Chandra and Kumar, 2018). The occurrence of these issues and challenges has a direct impact on the immunization rates in developing nations like India (Chandra and Kumar, 2018).…”

Modelo de Product Management para Emprendimientos

“…Según Rai et al (2023), el ROI como una medida oportuna y comparable de la eficiencia de una o más opciones de inversión. Esta métrica facilita las decisiones de las empresas para determinar una inversión, ya que manifiesta los costos como la gama completa de beneficios de una operación en las mismas unidades.…”